Results from the first sham-controlled trial of Cardiac Dimensions Inc.’s Carillon mitral contour system showed the implant can slow the progression of heart failure in patients with functional mitral regurgitation, also known as secondary mitral regurgitation.
Carillon is a right-heart transcatheter mitral valve repair device designed to treat primary functional mitral regurgitation grade 2+ or higher. It is deployed through a venous route starting in the jugular vein and it reshapes the mitral annulus so the separated mitral leaflets can close